M&A

Celanese sells more of Nutrinova to Mitsui for $152M to cut debt

What's the deal? CelaneseDealroom has a profile for this one. Try Dealroom → has sold an additional 19% stake in its NutrinovaDealroom has a profile for this one. Try Dealroom → food ingredients joint venture to Japan's Mitsui & Co.Dealroom has a profile for this one. Try Dealroom → for $152 million in cash. The US chemicals maker retains an 11% interest after the transaction, which closed in November 2026.

Why now? The sale advances Celanese's goal of raising about $1 billion in divestiture proceeds by the end of 2027. It also deepens a partnership that began in 2023, when Mitsui took a 70% stake in Nutrinova.

What's the endgame? Celanese plans to use the cash for deleveraging. It ended Q3 2026 with $10.2 billion in net debt and leverage of 4.9× net debt-to-operating EBITDA, and expects that ratio to ease to about 4.7× by year-end.

The divested stake contributed roughly $4 million in equity earnings in 2025 — a modest line against the balance-sheet challenge. Celanese expects around $650 million in divestiture proceeds by year-end, so the deal is one piece of a wider plan rather than a standalone turnaround.

What else? Celanese will temporarily own and operate a diketene facility at its Frankfurt chemical park to secure raw-material supply, then transfer it to Nutrinova. Nutrinova will bear all associated costs, including the purchase price.

The move follows a strong quarter. Celanese reported Q3 2026 adjusted earnings of $1.65 per share on $2.6 billion in sales, up 6% year on year, and raised its full-year free cash flow outlook to $750–800 million.

The signal: The sale shows Celanese chipping away at a heavy debt load through steady asset disposals rather than a single dramatic move. For Mitsui, it tightens control of a food-ingredients business it has been building since 2023.

Read more: zacks.com

Image credit: Nutrinova

More top stories